From: Doctors’ preferences in de-escalating DMARDs in rheumatoid arthritis: a discrete choice experiment
Rheumatologists (n = 117)a | Trainee (n = 28) | |
---|---|---|
Age (years), median (IQR) | 47 (40–57) | 34 (31–36) |
Female, n (%) | 60 (51%) | 20 (71%) |
Work experience (years), median (IQR) | 10 (5–23) | - |
Self-reported number of RA patients in practice, median (IQR) | 350 (200–1000) | 70 (25–100) |
Self-reported prevalence of biological treatment among RA patients in practice, median (IQR) | 25 (20–30) | 30 (20–35) |
Working in academic hospital, n (%) | 19 (16%) | 10 (36%) |